Method of Screening a Biological Target for Weak Interactions Using Weak Affinity Chromatography
AssigneeTransientic Interactions AB
InventorsSten Ohlson, Siamak Shoravi, Tomas Fex, Roland Isaksson
Life of this patent
Estimating the term…
Loading patent…
AssigneeTransientic Interactions AB
InventorsSten Ohlson, Siamak Shoravi, Tomas Fex, Roland Isaksson
Estimating the term…
The present invention relates to a method of screening a biological target for transient weak interactions between the target and a library of ligands. The method includes the provision of a composition comprising a biological target and the provision of a plurality of stationary phases from such a composition. A plurality of ligand compositions is transported to the stationary phases to establish contacts between the ligands and the biological targets. Zonal retardation information are collected for each ligand, downstream of the stationary phases in order to select ligands with dissociation constants (Kd) in the range of 0.01 to 10 mM, exhibiting weak affinity to the target.
A method of screening a biological target for transient weak interactions between the target and a library of ligands comprising the steps of:
Dependencies are inferred from the claim text.